Current heavy hitters in the clinical micro-market

Recently, I posted about the current heavy hitters in the clinical micro market – but who’s next up?

Endless innovation generally from the US is progressing into our U.K. / European Market, in the past year, we have seen T2 Biosystems enter a partnership with Werfen.

Below are some great examples of growing organisations based out of the US we could see one day enter the global marketplace.

– Pattern Bioscience led by Nicolas Arab and Ross Johnson has developed an excellent ‘Digital Culture™️’ product that delivers ID and AST Results in unision within four hours.

– Day Zero Diagnostics, Inc have created a new way of diagnosing infectious disease tests using sequencing and computerised learning to combat antibiotic-resistant infectious.

In case you missed the previous blog, here are some of the other major players:

– Bruker • Microbiology & Diagnostics
– bioMérieux
– Hologic, Inc.
– Cepheid
– BD
– QIAGEN

On a recruitment front, microbiology is a forever growing area with excellent innovation that arises YOY, if you are seeking a sales, application or marketing position for an organisation continuously offering market disruptive technology please do reach out to James Higgins.